Skip to main content
Top
Published in: Surgical Endoscopy 6/2017

01-06-2017

Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample

Authors: Hans F. Fuchs, Cristina R. Harnsberger, Ryan C. Broderick, David C. Chang, Bryan J. Sandler, Garth R. Jacobsen, Michael Bouvet, Santiago Horgan

Published in: Surgical Endoscopy | Issue 6/2017

Login to get access

Abstract

Background

The effects of hospital volume on in-hospital mortality after esophageal resection are disputed in the literature. We sought to analyze treatment effects in patient subpopulations that undergo esophagectomy for cancer based on hospital volume.

Methods

We performed a retrospective analysis of the Nationwide Inpatient Sample from 1998 to 2011. Patients who underwent open or laparoscopic transhiatal and transthoracic esophageal resection were identified using ICD-9 codes. Patients <18 years and those with peritoneal disease were excluded. Multivariate logistic regression analyses were used with mortality as the independent variable to evaluate the effect of low (<6), intermediate (6–19), and high (20) hospital volume of esophagectomies. These analyses were repeated in different subsets of patients to determine whether hospital volume affected mortality depending on the subpopulation evaluated. Subgroups were created depending on age, race, gender, operative approach, comorbidities, and tumor pathology.

Results

A total of 23,751 patients were included. The overall perioperative mortality rate was 7.7 % (low volume: 11.4 %; intermediate volume: 8.39 %, high volume: 4.01 %), and multivariate analysis revealed that high hospital volume had a protective effect (OR 0.54, 95 % CI 0.45–0.65). On subgroup analyses for low- and intermediate-volume hospitals, mortality was uniformly elevated for the subpopulations when comparing to high-volume hospitals (p < 0.05). There was no difference in mortality between low- and medium-volume hospitals and between subgroups.

Conclusion

No lower mortality risk subgroup could be identified in this nationwide collective. This analysis emphasizes that perioperative mortality after esophagectomy for cancer is lower in high-volume hospitals.
Literature
1.
go back to reference Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed
2.
go back to reference Pech O, Manner H, Ell C, Bollschweiler E, Hölscher AH (2013) Reply to letter: “For patients with early esophageal cancer endoscopic mucosa resection is not the end of the story!”. Ann Surg 257(6):e22–e23CrossRefPubMed Pech O, Manner H, Ell C, Bollschweiler E, Hölscher AH (2013) Reply to letter: “For patients with early esophageal cancer endoscopic mucosa resection is not the end of the story!”. Ann Surg 257(6):e22–e23CrossRefPubMed
3.
go back to reference Metzger R, Lorenz D, Gockel I, Origer J, Plum PS, Junginger T, Drebber U, Hansen T, Krümpelmann K, Fisseler-Eckhoff A, Lang H, Hölscher AH, Bollschweiler E (2013) pT2 adenocarcinoma of the esophagus: early or advanced cancer? Ann Thorac Surg 96(5):1840–1845CrossRefPubMed Metzger R, Lorenz D, Gockel I, Origer J, Plum PS, Junginger T, Drebber U, Hansen T, Krümpelmann K, Fisseler-Eckhoff A, Lang H, Hölscher AH, Bollschweiler E (2013) pT2 adenocarcinoma of the esophagus: early or advanced cancer? Ann Thorac Surg 96(5):1840–1845CrossRefPubMed
4.
go back to reference Fuchs HF, Hölscher AH (2014) Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer. Zentralbl Chir 139(1):32–36 (Review. German) CrossRefPubMed Fuchs HF, Hölscher AH (2014) Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer. Zentralbl Chir 139(1):32–36 (Review. German) CrossRefPubMed
5.
go back to reference Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR (2014) Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer—a propensity score matched analysis. Eur J Cancer 50(17):2950–2957CrossRefPubMed Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR (2014) Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer—a propensity score matched analysis. Eur J Cancer 50(17):2950–2957CrossRefPubMed
6.
go back to reference van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed
7.
go back to reference Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232(2):225–232CrossRefPubMedPubMedCentral Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232(2):225–232CrossRefPubMedPubMedCentral
8.
go back to reference Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239(4):483–490CrossRefPubMedPubMedCentral Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239(4):483–490CrossRefPubMedPubMedCentral
9.
go back to reference Mariette C, Taillier G, Van Seuningen I, Triboulet JP (2004) Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 78(4):1177–1183CrossRefPubMed Mariette C, Taillier G, Van Seuningen I, Triboulet JP (2004) Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 78(4):1177–1183CrossRefPubMed
10.
go back to reference Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240(5):791–800CrossRefPubMedPubMedCentral Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240(5):791–800CrossRefPubMedPubMedCentral
11.
go back to reference Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256(1):95–103CrossRefPubMedPubMedCentral Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256(1):95–103CrossRefPubMedPubMedCentral
12.
go back to reference Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H (2003) A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 90(1):108–113 (Erratum in: Br J Surg 90(6):764) CrossRefPubMed Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H (2003) A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 90(1):108–113 (Erratum in: Br J Surg 90(6):764) CrossRefPubMed
13.
go back to reference Coker AM, Barajas-Gamboa JS, Cheverie J, Jacobsen GR, Sandler BJ, Talamini MA, Bouvet M, Horgan S (2014) Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation. J Laparoendosc Adv Surg Tech A 24(2):89–94CrossRefPubMed Coker AM, Barajas-Gamboa JS, Cheverie J, Jacobsen GR, Sandler BJ, Talamini MA, Bouvet M, Horgan S (2014) Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation. J Laparoendosc Adv Surg Tech A 24(2):89–94CrossRefPubMed
14.
go back to reference Zhang J, Wang R, Liu S, Luketich JD, Chen S, Chen H, Schuchert MJ (2012) Refinement of minimally invasive esophagectomy techniques after 15 years of experience. J Gastrointest Surg 16(9):1768–1774CrossRefPubMed Zhang J, Wang R, Liu S, Luketich JD, Chen S, Chen H, Schuchert MJ (2012) Refinement of minimally invasive esophagectomy techniques after 15 years of experience. J Gastrointest Surg 16(9):1768–1774CrossRefPubMed
15.
go back to reference Schröder W, Hölscher AH, Bludau M, Vallböhmer D, Bollschweiler E, Gutschow C (2010) Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg 34(4):738–743CrossRefPubMed Schröder W, Hölscher AH, Bludau M, Vallböhmer D, Bollschweiler E, Gutschow C (2010) Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg 34(4):738–743CrossRefPubMed
16.
go back to reference Fuchs HF, Broderick RC, Harnsberger CR, Divo FA, Coker AM, Jacobsen GR, Sandler BJ, Bouvet M, Horgan S (2016) Intraoperative endoscopic botox injection during total esophagectomy prevents the need for pyloromyotomy or dilatation. J Laparoendosc Adv Surg Tech A 26(6):433–438. doi:10.1089/lap.2015.0575 CrossRefPubMed Fuchs HF, Broderick RC, Harnsberger CR, Divo FA, Coker AM, Jacobsen GR, Sandler BJ, Bouvet M, Horgan S (2016) Intraoperative endoscopic botox injection during total esophagectomy prevents the need for pyloromyotomy or dilatation. J Laparoendosc Adv Surg Tech A 26(6):433–438. doi:10.​1089/​lap.​2015.​0575 CrossRefPubMed
17.
go back to reference Fuchs HF, Harnsberger CR, Broderick RC, Chang DC, Sandler BJ, Jacobsen GR, Bouvet M, Horgan S (2016) Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy. Dis Esophagus. doi:10.1111/dote.12451 PubMed Fuchs HF, Harnsberger CR, Broderick RC, Chang DC, Sandler BJ, Jacobsen GR, Bouvet M, Horgan S (2016) Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy. Dis Esophagus. doi:10.​1111/​dote.​12451 PubMed
18.
go back to reference Mitikiri ND, Reese ES, Hussain A, Onukwugha E, Pritchard D, Dubois R, Mullins CD (2013) The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model. J Comp Eff Res 2(6):605–618CrossRefPubMed Mitikiri ND, Reese ES, Hussain A, Onukwugha E, Pritchard D, Dubois R, Mullins CD (2013) The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model. J Comp Eff Res 2(6):605–618CrossRefPubMed
20.
go back to reference Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed
21.
go back to reference Blencowe NS, Strong S, McNair AG, Brookes ST, Crosby T, Griffin SM, Blazeby JM (2012) Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 255(4):658–666CrossRefPubMed Blencowe NS, Strong S, McNair AG, Brookes ST, Crosby T, Griffin SM, Blazeby JM (2012) Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 255(4):658–666CrossRefPubMed
22.
go back to reference Dimick JB, Cowan JA Jr, Ailawadi G, Wainess RM, Upchurch GR (2003) National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch Surg 138(12):1305–1309CrossRefPubMed Dimick JB, Cowan JA Jr, Ailawadi G, Wainess RM, Upchurch GR (2003) National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch Surg 138(12):1305–1309CrossRefPubMed
23.
go back to reference Connors RC, Reuben BC, Neumayer LA, Bull DA (2007) Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 205(6):735–740CrossRefPubMed Connors RC, Reuben BC, Neumayer LA, Bull DA (2007) Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 205(6):735–740CrossRefPubMed
24.
go back to reference Kohn GP, Galanko JA, Meyers MO, Feins RH, Farrell TM (2009) National trends in esophageal surgery—are outcomes as good as we believe? J Gastrointest Surg 213(11):1900–1910 (discussion 1910–1912) CrossRef Kohn GP, Galanko JA, Meyers MO, Feins RH, Farrell TM (2009) National trends in esophageal surgery—are outcomes as good as we believe? J Gastrointest Surg 213(11):1900–1910 (discussion 1910–1912) CrossRef
25.
go back to reference Lapar DJ, Stukenborg GJ, Lau CL, Jones DR, Kozower BD (2012) Differences in reported esophageal cancer resection outcomes between national clinical and administrative databases. J Thorac Cardiovasc Surg 144(5):1152–1157CrossRefPubMed Lapar DJ, Stukenborg GJ, Lau CL, Jones DR, Kozower BD (2012) Differences in reported esophageal cancer resection outcomes between national clinical and administrative databases. J Thorac Cardiovasc Surg 144(5):1152–1157CrossRefPubMed
26.
go back to reference Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR (1995) Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 76(2):178–186CrossRefPubMed Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR (1995) Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 76(2):178–186CrossRefPubMed
27.
go back to reference Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85(6):840–844CrossRefPubMed Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85(6):840–844CrossRefPubMed
28.
go back to reference Bollschweiler E, Schröder W, Hölscher AH, Siewert JR (2000) Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 87(8):1106–1110CrossRefPubMed Bollschweiler E, Schröder W, Hölscher AH, Siewert JR (2000) Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 87(8):1106–1110CrossRefPubMed
29.
go back to reference Kozower BD, Stukenborg GJ (2012) Hospital esophageal cancer resection volume does not predict patient mortality risk. Ann Thorac Surg 93(5):1690–1696 (discussion 1696–1698) CrossRefPubMed Kozower BD, Stukenborg GJ (2012) Hospital esophageal cancer resection volume does not predict patient mortality risk. Ann Thorac Surg 93(5):1690–1696 (discussion 1696–1698) CrossRefPubMed
30.
go back to reference Metzger R, Bollschweiler E, Vallböhmer D, Maish M, DeMeester TR, Hölscher AH (2004) High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 17(4):310–314CrossRefPubMed Metzger R, Bollschweiler E, Vallböhmer D, Maish M, DeMeester TR, Hölscher AH (2004) High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 17(4):310–314CrossRefPubMed
31.
go back to reference Milstein A, Galvin RS, Delbanco SF, Salber P, Buck CR (2001) Improving the safety of health care: the leapfrog initiative. Eff Clin Pract 3(6):313–316 (Erratum in: Eff Clin Pract 4(2):94) Milstein A, Galvin RS, Delbanco SF, Salber P, Buck CR (2001) Improving the safety of health care: the leapfrog initiative. Eff Clin Pract 3(6):313–316 (Erratum in: Eff Clin Pract 4(2):94)
32.
go back to reference Munasinghe A, Markar SR, Mamidanna R, Darzi AW, Faiz OD, Hanna GB, Low DE (2015) Is it time to centralize high-risk cancer care in the United States? Comparison of outcomes of esophagectomy between England and the United States. Ann Surg 262(1):79–85CrossRefPubMed Munasinghe A, Markar SR, Mamidanna R, Darzi AW, Faiz OD, Hanna GB, Low DE (2015) Is it time to centralize high-risk cancer care in the United States? Comparison of outcomes of esophagectomy between England and the United States. Ann Surg 262(1):79–85CrossRefPubMed
33.
go back to reference Klabunde CN, Warren JL, Legler JM (2002) Assessing comorbidity using claims data: an overview. Med Care 40(8):IV-26–IV-35 Klabunde CN, Warren JL, Legler JM (2002) Assessing comorbidity using claims data: an overview. Med Care 40(8):IV-26–IV-35
34.
go back to reference Chang DC, Evans C, Parker J (2015) Conceptualizing administrative databases as screening tools for health system quality: rethinking the issue of data accuracy. JAMA Surg 150(1):5–6CrossRefPubMed Chang DC, Evans C, Parker J (2015) Conceptualizing administrative databases as screening tools for health system quality: rethinking the issue of data accuracy. JAMA Surg 150(1):5–6CrossRefPubMed
35.
go back to reference Fuchs HF, Broderick RC, Harnsberger CR, Chang DC, Sandler BJ, Jacobsen GR, Horgan S (2015) Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A 25(3):196–201CrossRefPubMed Fuchs HF, Broderick RC, Harnsberger CR, Chang DC, Sandler BJ, Jacobsen GR, Horgan S (2015) Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A 25(3):196–201CrossRefPubMed
36.
go back to reference Mariette C, Meunier B, Pezet D, Dalban C, Collet D, Thomas PA, Brigand C, Perniceni T, Carrere N, Bonnetain F, Piessen G (2015) Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicenter, open-label, randomized phase III controlled trial, the MIRO trial. J Clin Oncol 33(Suppl 3):abstr 5 Mariette C, Meunier B, Pezet D, Dalban C, Collet D, Thomas PA, Brigand C, Perniceni T, Carrere N, Bonnetain F, Piessen G (2015) Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicenter, open-label, randomized phase III controlled trial, the MIRO trial. J Clin Oncol 33(Suppl 3):abstr 5
Metadata
Title
Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample
Authors
Hans F. Fuchs
Cristina R. Harnsberger
Ryan C. Broderick
David C. Chang
Bryan J. Sandler
Garth R. Jacobsen
Michael Bouvet
Santiago Horgan
Publication date
01-06-2017
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 6/2017
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5251-9

Other articles of this Issue 6/2017

Surgical Endoscopy 6/2017 Go to the issue